| Literature DB >> 35075971 |
Vincent Camus1,2, Mathieu Viennot2, Emilie Lévêque3, Pierre-Julien Viailly2, David Tonnelet4, Elena-Liana Veresezan5, Fanny Drieux5, Pascaline Etancelin6, Sydney Dubois1,2, Aspasia Stamatoullas1,2, Hervé Tilly1,2, Elodie Bohers2, Fabrice Jardin1,2.
Abstract
Few data exist concerning circulating tumor DNA (ctDNA) relevance in primary mediastinal B-cell lymphoma (PMBL). To explore this topic, we applied a 9-gene next-generation sequencing pipeline to samples from forty-four PMBL patients (median age 36.5 years). The primary endpoint was a similarity between paired biopsy/plasma mutational profiles. We detected at least one variant in 32 plasma samples (80%). The similarity between the biopsy and ctDNA genetic profiles for the 30 patients with paired mutated biopsy/plasma samples was greater than or equal to 80% in 19 patients (63.3%). We then compared PMBL ctDNA features with those of a cohort of Hodgkin lymphoma patients (n = 60). The top three mutated genes were SOCS1, TNFAIP3, and B2M in both lymphoma types. PMBL displayed more alterations in TNFAIP3 (71.9% vs. 46.3%, p = 0.029) and GNA13 (46.9% vs. 17.1%, p = 0.013) than cHL. Our 9-gene set may delineate tumor genotypes using ctDNA samples from both lymphoma types.Entities:
Keywords: Primary mediastinal large B cell lymphoma; cell-free DNA; circulating tumor DNA; classical Hodgkin lymphoma
Mesh:
Substances:
Year: 2022 PMID: 35075971 DOI: 10.1080/10428194.2021.2010060
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022